In the context of our study, the observed activation of proteasome, inhibition of mismatch repair (MMR), and the negative correlation with retinol metabolism pathways, as well as the differential GO terms, offer important insights into the complex mechanisms underlying GLI1-mediated breast cancer progression. The gene discussed is GLI1; the disease is breast carcinoma.